Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | STZ | AMCR |
|---|---|---|
| Price | $113.03 | $41.78 |
| Change today | ▼ 0.03% | ▼ 0.19% |
| Market cap | $19.30B | $19.32B |
| Return, 3 months | -16.8% | -2.9% |
| Return, year to date | -16.3% | +4.7% |
| Return, 1 year | -16.2% | +8.2% |
| P/E (TTM) | 10.8 | 17.6 |
| P/B | 2.3 | 1.6 |
| P/E percentile vs own 5y | 30th | 30th |
| Dividend yield | 3.62% | 6.19% |
| Revenue growth (YoY, latest qtr) | -3.3% | +25.9% |
| Net profit growth (YoY) | +28.3% | +1,097.4% |
| Gross margin | 52.6% | 20.0% |
| Operating margin | 32.7% | 9.3% |
| Net margin | 20.1% | 4.7% |
| Return on equity | 23.5% | 9.4% |
| Analyst target vs. price | +45.7% | +17.0% |
| Analyst buy share | 73% | 56% |
| RSI (14) | 25 | 39 |
| 30-day volatility | 24.6% | 22.8% |
| Max drawdown, 1 year | -31.3% | -26.5% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
